10-8074116-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001002295.2(GATA3):​c.*93C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0239 in 1,408,806 control chromosomes in the GnomAD database, including 2,126 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.026 ( 234 hom., cov: 32)
Exomes 𝑓: 0.024 ( 1892 hom. )

Consequence

GATA3
NM_001002295.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.849

Publications

14 publications found
Variant links:
Genes affected
GATA3 (HGNC:4172): (GATA binding protein 3) This gene encodes a protein which belongs to the GATA family of transcription factors. The protein contains two GATA-type zinc fingers and is an important regulator of T-cell development and plays an important role in endothelial cell biology. Defects in this gene are the cause of hypoparathyroidism with sensorineural deafness and renal dysplasia. [provided by RefSeq, Nov 2009]
GATA3 Gene-Disease associations (from GenCC):
  • hypoparathyroidism-deafness-renal disease syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-8074116-C-T is Benign according to our data. Variant chr10-8074116-C-T is described in ClinVar as Benign. ClinVar VariationId is 301131.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.249 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GATA3NM_001002295.2 linkc.*93C>T 3_prime_UTR_variant Exon 6 of 6 ENST00000379328.9 NP_001002295.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GATA3ENST00000379328.9 linkc.*93C>T 3_prime_UTR_variant Exon 6 of 6 1 NM_001002295.2 ENSP00000368632.3
GATA3ENST00000346208.4 linkc.*93C>T 3_prime_UTR_variant Exon 6 of 6 1 ENSP00000341619.3
GATA3ENST00000461472.1 linkc.*373C>T downstream_gene_variant 3 ENSP00000515407.1

Frequencies

GnomAD3 genomes
AF:
0.0262
AC:
3988
AN:
152122
Hom.:
235
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00480
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0123
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.261
Gnomad SAS
AF:
0.0702
Gnomad FIN
AF:
0.102
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0112
Gnomad OTH
AF:
0.0191
GnomAD4 exome
AF:
0.0236
AC:
29686
AN:
1256566
Hom.:
1892
Cov.:
18
AF XY:
0.0246
AC XY:
15365
AN XY:
625492
show subpopulations
African (AFR)
AF:
0.00515
AC:
145
AN:
28156
American (AMR)
AF:
0.0232
AC:
762
AN:
32906
Ashkenazi Jewish (ASJ)
AF:
0.00759
AC:
167
AN:
22006
East Asian (EAS)
AF:
0.275
AC:
10349
AN:
37652
South Asian (SAS)
AF:
0.0545
AC:
4075
AN:
74756
European-Finnish (FIN)
AF:
0.0958
AC:
4064
AN:
42436
Middle Eastern (MID)
AF:
0.0125
AC:
65
AN:
5184
European-Non Finnish (NFE)
AF:
0.00888
AC:
8531
AN:
960406
Other (OTH)
AF:
0.0288
AC:
1528
AN:
53064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1417
2833
4250
5666
7083
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0262
AC:
3989
AN:
152240
Hom.:
234
Cov.:
32
AF XY:
0.0322
AC XY:
2396
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.00476
AC:
198
AN:
41572
American (AMR)
AF:
0.0123
AC:
188
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0107
AC:
37
AN:
3470
East Asian (EAS)
AF:
0.261
AC:
1347
AN:
5166
South Asian (SAS)
AF:
0.0715
AC:
345
AN:
4828
European-Finnish (FIN)
AF:
0.102
AC:
1076
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0112
AC:
759
AN:
68006
Other (OTH)
AF:
0.0185
AC:
39
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
180
360
540
720
900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0111
Hom.:
57
Bravo
AF:
0.0204
Asia WGS
AF:
0.120
AC:
414
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hypoparathyroidism, deafness, renal disease syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.19
DANN
Benign
0.58
PhyloP100
-0.85
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229360; hg19: chr10-8116079; COSMIC: COSV60523713; COSMIC: COSV60523713; API